Biote Corp. declined 1.74% in intraday trading, with BB Biotech AG reporting a net loss of CHF 241 million for Q1 2025. The company's share price closed the quarter at a lower value due to elevated market volatility and rising macro uncertainty, driven by geopolitical developments and trade tensions.
Comments
No comments yet